Standardized evaluation protocol improved transfer, ECSL outcomes, and re-transfer to discharge for pediatric hematologic oncology patients.

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

NORTON, Va. (WJHL) — In a Hematology/Oncology practice, every day brings challenges and heart. November’s Nurse Of The Month, ...

The 5-year lung cancer survival rate has increased more than 25% over the past decade, highlighting the impact of increased ...

Media ReleaseCOPENHAGEN, Denmark; November 3, 2025 More than 20 abstracts, including seven oral presentations, highlight advancements from the epcoritamab development program supporting the expanded ...

Flatiron Health today announced its presence at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition happening from December 6-9, 2025, in Orlando, Florida. Flatiron's ...

The 5th Binaytara Precision Oncology Summit, a two-day conference chaired by Dr. Mark Pegram, convenes in San Francisco on October 24-25, 2025. The summit is dedicated to redefining cancer treatment ...

Friends for Hope is celebrating its 20th anniversary with the Heroes and Outlaws concert, featuring Grammy award-winning ...

Gamze Yüceland advances dialogue with Saudi healthcare leaders to accelerate sector transformation and align with Vision 2030 ...

PureTech to Present New Data from Ongoing Phase 1b Trial of LYT-200 in Relapsed/Refractory Acute Myeloid Leukemia (AML) at ASH Annual Meeting ...

Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines in oncology ...

A cross-continental study suggests that in the treatment of acute myeloid leukemia, age affects survival, independent of ...